영상 내 비주얼 특징을 이용한 영상 요약 방법 및 시스템
    1.
    发明授权
    영상 내 비주얼 특징을 이용한 영상 요약 방법 및 시스템 有权
    视频摘要方法和系统使用视频中的视觉特征

    公开(公告)号:KR101341808B1

    公开(公告)日:2013-12-17

    申请号:KR1020120125545

    申请日:2012-11-07

    Abstract: 본발명은영상내 비주얼특징을이용한영상요약방법및 시스템에관한것으로, 보다구체적으로는영상으로부터저수준특징벡터를이용하여적어도하나의비디오샷을검출한후, 검출된비디오샷을대표하는키프레임을검출하는키프레임검출단계; 검출된상기키프레임내 얼굴을검출하고, 얼굴이검출된키프레임을군집화하여등장인물을검출하는등장인물검출단계; 등장인물이검출된상기키프레임내 등장인물의노출횟수, 상기얼굴이검출된키프레임의저수준특징벡터에기초하여키프레임간거리가기설정된임계값보다작은거리를갖는키프레임들을포함하는키프레임군집을검출하고, 검출된키프레임군집내 각키프레임에대하여중요도를연산하는중요도연산단계; 및사용자로부터요청받은키프레임수에따라, 중요도가높은순서별로해당하는키프레임을선별하여추출하는선별단계;를포함한다. 이러한구성에의해, 본발명의영상내 비주얼특징을이용한영상요약방법및 시스템은요약하고자하는영상내 등장인물, 키프레임의샷길이및 색상정보와같은비주얼특징을이용하여상기영상내 키프레임에대한중요도를연산한후, 연산한중요도에기초하여키프레임을선별함에따라, 영상을용이하게요약할수 있는효과가있다.

    영상 내 비주얼 특징을 이용한 영상 요약 방법 및 시스템
    2.
    发明公开
    영상 내 비주얼 특징을 이용한 영상 요약 방법 및 시스템 有权
    视频摘要方法和使用视频中的视觉特征的系统

    公开(公告)号:KR1020130061058A

    公开(公告)日:2013-06-10

    申请号:KR1020120125545

    申请日:2012-11-07

    CPC classification number: G06K9/00751 G06K9/00288

    Abstract: PURPOSE: An image summary method using visual features in images and a system thereof are provided to calculate significance for a key frame in the images by using the visual features in the images and to select the key frame based on the significance, thereby summarizing the images. CONSTITUTION: An image summary system detects one or more video shots from images and detects a key frame which shows the detected video shot(S210). The image summary system detects a face from the detected key frame and detects a character after grouping key frames which the face is detected(S220). The image summary system detects a key frame group and calculates significance for each key frame in the detected key frame group(S230). The image summary system selects and extracts the key frame corresponding to the number of requested key frame(S240). [Reference numerals] (AA) Start; (BB) End; (S210) Detect one or more video shots and detect a key frame which represents the detected video shot from images by using a low level feature vector; (S220) Detect a face for a character in the detected key frame, group the detected key frame with the face, and detect the character; (S230) Detect a key frame group including the key frames having a smaller distance between the key frames than a predetermined threshold value and calculate significance for each key frame in the detected key frame group; (S240) Select and extract the key frame corresponding to the number of requested key frame by a user in order of significance

    Abstract translation: 目的:提供使用图像中的视觉特征及其系统的图像汇总方法,以通过使用图像中的视觉特征来计算图像中的关键帧的重要性,并且基于重要性来选择关键帧,从而总结图像 。 构成:图像汇总系统检测图像中的一个或多个视频图像,并检测显示检测到的视频拍摄的关键帧(S210)。 图像汇总系统从检测到的关键帧中检测出面部,并且在检测到面部的关键帧分组之后检测出角色(S220)。 图像汇总系统检测关键帧组并计算检测到的关键帧组中每个关键帧的重要性(S230)。 图像汇总系统选择并提取与所请求的关键帧数相对应的关键帧(S240)。 (附图标记)(AA)开始; (BB)结束; (S210)通过使用低级特征向量检测一个或多个视频镜头并检测表示从图像拍摄的视频镜头的关键帧; (S220)检测检测到的关键帧中的字符的面部,将检测到的关键帧与脸部对齐,并检测字符; (S230)检测包括关键帧之间的距离小于预定阈值的关键帧的关键帧组,并计算检测到的关键帧组中的每个关键帧的重要性; (S240)按用户的顺序选择并提取与请求的关键帧数相对应的关键帧

    당뇨병성 신증 진단용 바이오 마커
    3.
    发明授权
    당뇨병성 신증 진단용 바이오 마커 有权
    生物标记用于诊断糖尿病性肾病

    公开(公告)号:KR100792630B1

    公开(公告)日:2008-01-09

    申请号:KR1020060063108

    申请日:2006-07-05

    CPC classification number: G01N33/6893 G01N2333/775 G01N2800/042

    Abstract: A bio marker for diagnosing diabetic nephropathy is provided to identify the attack of the diabetic nephropathy from a human blood and the initial diagnosis and the progress stage of the diabetic nephropathy in diabetes. A bio marker composition comprises a protein decreasing in a blood of a patient suffering from the diabetic nephropathy than in a blood of a diabetic individual and selected from the group consisting of: c-type lectin domain family 3, member B having an amino acid sequence of SEQ ID : NO. 1, a molecular weight of 22-24kD and pI of 5.0-6.0; apolipoprotein CIII having an amino acid sequence of SEQ ID : NO. 2, a molecular weight of 8-10kD and pI of 4.2-5.2; retinol binding protein 4 having an amino acid sequence of SEQ ID : NO. 3, a molecular weight of 22-24kD and pI of 4.9-5.9; proapo-A-I protein having an amino acid sequence of SEQ ID : NO. 4, a molecular weight of 28-30kD and pI of 4.9-5.9; ficolin 3 precursor having an amino acid sequence of SEQ ID : NO. 5, a molecular weight of 32-34kD and pI of 5.7-6.7; vitamin D binding protein precursor having an amino acid sequence of SEQ ID : NO. 6, a molecular weight of 54-56kD and pI of 5.0-6.0; histidine-rich glycoprotein having an amino acid sequence of SEQ ID : NO. 7, a molecular weight of 39-41kD and pI of 3.4-4.4; complement factor H-related 1 having an amino acid sequence of SEQ ID : NO. 8, a molecular weight of 38-40kD and pI of 7.3-8.3; haptoglobin-related protein precursor having an amino acid sequence of SEQ ID : NO. 9, a molecular weight of 38-40kD and pI of 6.2-7.2; hemopexin precursor having an amino acid sequence of SEQ ID : NO. 10, a molecular weight of 51-53kD and pI of 6.1-7.1; complement factor I light chain having an amino acid sequence of SEQ ID : NO. 11, a molecular weight of 22-24kD and pI of 4.7-5.7; sex hormone-binding globulin having an amino acid sequence of SEQ ID : NO. 12, a molecular weight of 43-45kD and pI of 5.7-6.7; apolipoprotein E having an amino acid sequence of SEQ ID : NO. 13, a molecular weight of 35-37kD and pI of 5.2-6.2; and plasma glutathione peroxidase precursor having an amino acid sequence of SEQ ID : NO. 14, a molecular weight of 25-27kD and pI of 7.7-8.7.

    Abstract translation: 提供用于诊断糖尿病肾病的生物标志物,用于鉴定人血糖的糖尿病肾病的发作及糖尿病肾病的初步诊断和进展阶段。 生物标志物组合物包含在患有糖尿病肾病的患者的血液中比在糖尿病个体的血液中降低的蛋白质,并且选自:c型凝集素结构域家族3,具有氨基酸序列的成员B SEQ ID NO: 1,分子量22-24kD,pI为5.0-6.0; 具有SEQ ID NO:1的氨基酸序列的载脂蛋白CIII。 2,分子量为8-10kD,pI为4.2-5.2; 视黄醇结合蛋白4具有SEQ ID NO:1的氨基酸序列。 3,分子量22-24kD,pI为4.9-5.9; 具有SEQ ID NO:1的氨基酸序列的proapo-A-I蛋白。 4,分子量28-30kD,pI为4.9-5.9; 具有SEQ ID NO:1的氨基酸序列的ficolin 3前体。 5,分子量32-34kD,pI为5.7-6.7; 具有SEQ ID NO:1的氨基酸序列的维生素D结合蛋白前体。 6,分子量为54-56kD,pI为5.0-6.0; 富含组氨酸的糖蛋白,其氨基酸序列为SEQ ID NO: 7,分子量39-41kD,pI为3.4-4.4; 具有SEQ ID NO:1的氨基酸序列的补体因子H相关1。 8,分子量38-40kD,pI为7.3-8.3; 具有SEQ ID NO:1的氨基酸序列的触珠蛋白相关蛋白前体。 9,分子量38-40kD,pI为6.2-7.2; 具有SEQ ID NO:1的氨基酸序列的血红蛋白前体。 10,分子量为51-53kD,pI为6.1-7.1; 具有SEQ ID NO:1的氨基酸序列的补体因子I轻链。 11,分子量22-24kD,pI为4.7-5.7; 具有SEQ ID NO:1的氨基酸序列的性激素结合球蛋白。 12,分子量43-45kD,pI为5.7-6.7; 具有SEQ ID NO:1的氨基酸序列的载脂蛋白E。 13,分子量35-37kD,pI为5.2-6.2; 和具有SEQ ID NO:1的氨基酸序列的血浆谷胱甘肽过氧化物酶前体。 14,分子量25-27kD,pI为7.7-8.7。

    문자 콜라주 메시지 생성 장치 및 방법
    4.
    发明公开
    문자 콜라주 메시지 생성 장치 및 방법 有权
    创建文本信息的设备和方法

    公开(公告)号:KR1020120020892A

    公开(公告)日:2012-03-08

    申请号:KR1020100084813

    申请日:2010-08-31

    CPC classification number: G06T11/00 H04W4/12 G06F7/08 H04B1/40 H04W88/02

    Abstract: PURPOSE: A device for generating a text collage message and a method thereof are provided to generate a text image corresponding to a text by a text collage message, thereby sending the message to a mobile terminal of a counterpart person. CONSTITUTION: A text recognizing unit(11) recognizes a text of an image. A text image generating unit(12) generates a fixed area including the recognized text by a text image. A control unit(16) outputs texts inputted by an input unit(14) to an output unit(15). The control unit replaces at least some texts corresponding to a text image stored in a storage unit with the text image.

    Abstract translation: 目的:提供一种用于生成文本拼贴消息的装置及其方法,用于通过文本拼贴消息生成与文本相对应的文本图像,从而将消息发送到对方的移动终端。 构成:文本识别单元(11)识别图像的文本。 文本图像生成单元(12)通过文本图像生成包括识别的文本的固定区域。 控制单元(16)将由输入单元(14)输入的文本输出到输出单元(15)。 控制单元将存储在存储单元中的文本图像对应的至少一些文本替换为文本图像。

    문자 콜라주 메시지 생성 장치 및 방법
    5.
    发明授权
    문자 콜라주 메시지 생성 장치 및 방법 有权
    创建文本信息的设备和方法

    公开(公告)号:KR101659091B1

    公开(公告)日:2016-09-22

    申请号:KR1020100084813

    申请日:2010-08-31

    CPC classification number: G06T11/00

    Abstract: 본발명에따른문자콜라주메시지생성장치는문자를포함한이미지로부터상기문자를인식하는문자인식부; 상기이미지로부터상기인식된문자를포함하는소정의영역을추출하여문자이미지를생성하는문자이미지생성부; 상기생성된문자이미지를저장하는저장부; 입력부를통해입력되는복수의문자들을출력부에출력하고, 상기복수의문자들중 상기저장부에저장된문자이미지에대응되는적어도일부의문자를상기문자이미지로교체하여상기출력부에출력하고, 상기출력된문자와문자이미지를포함하는문자콜라주메시지를생성하는제어부; 및상기문자콜라주메시지를무선으로송수신하는통신부를포함하고, 상기제어부는, 상기통신부를통해수신된문자콜라주메시지로부터문자이미지들을추출하여상기저장부에저장하고, 특정문자에복수의문자이미지들이대응되는경우, 상기복수의문자이미지들중 하나를우선순위문자이미지로설정하여상기특정문자에우선적으로대응시켜상기수신된문자콜라주메시지를상기출력부에출력하는것을특징으로한다.

Patent Agency Ranking